The Disparities in Myasthenia Gravis Clinical Trial Enrollment in the United States and Canada

Documenti analoghi

• Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task Force
  di: Katherine Ruzhansky, et al.
  Pubblicazione: (2025)
• Comparison of the Quantitative Myasthenia Gravis and Myasthenia Gravis Activity of Daily Living Scores From a Clinical Practice Perspective
  di: Wanqing Wu, et al.
  Pubblicazione: (2025)
• Risk of Infection Following Clearance of Immunoglobulin G by Plasma Exchange in Myasthenia Gravis
  di: Eric B. Creed, et al.
  Pubblicazione: (2026)
• Light Sensitivity in Myasthenia Gravis: Clinical Characteristics and Impact on Quality of Life
  di: Eleonora Sabatelli, et al.
  Pubblicazione: (2025)
• Diaphragmatic Compound Muscle Action Potentials Correlate With the Clinical Severity of Myasthenia Gravis
  di: Hirotomo Suehiro, et al.
  Pubblicazione: (2025)